Thus, investigations into NLRP3 inflammasome will shed light on the pathogenesis of cardiovascular diseases and provide critical clues for seeking new targets for clinical cardiovascular diseases drug development. This evidence concerns the gene NLRP3 and cardiovascular disorder.